151 related articles for article (PubMed ID: 8985641)
1. Effect of hybrid peptides of cecropin A and melittin in an experimental model of bacterial keratitis.
Nos-Barbera S; Portoles M; Morilla A; Ubach J; Andreu D; Paterson CA
Cornea; 1997 Jan; 16(1):101-6. PubMed ID: 8985641
[TBL] [Abstract][Full Text] [Related]
2. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
[TBL] [Abstract][Full Text] [Related]
3. Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis.
Michalová K; Moyes AL; Cameron S; Juni BA; Obritsch WF; Dvorak JA; Doughman DJ; Rhame FS
Cornea; 1996 Sep; 15(5):533-6. PubMed ID: 8862931
[TBL] [Abstract][Full Text] [Related]
4. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS
Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638
[TBL] [Abstract][Full Text] [Related]
5. Nona-D-arginine therapy for Pseudomonas aeruginosa keratitis.
Karicherla P; Hobden JA
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):256-62. PubMed ID: 18775859
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Oguz H; Ozbilge H; Oguz E; Gurkan T
Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
[TBL] [Abstract][Full Text] [Related]
7. Effect of systemic tetracycline on progression of Pseudomonas aeruginosa keratitis in the rabbit.
Levy JH; Katz HR
Ann Ophthalmol; 1990 May; 22(5):179-83. PubMed ID: 2114813
[TBL] [Abstract][Full Text] [Related]
8. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
Mannis MJ
Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis.
Engel LS; Callegan MC; Hill JM; Folkens AT; Shimomura Y; O'Callaghan RJ
Jpn J Ophthalmol; 1996; 40(2):212-9. PubMed ID: 8876389
[TBL] [Abstract][Full Text] [Related]
10. In vivo performance of melimine as an antimicrobial coating for contact lenses in models of CLARE and CLPU.
Cole N; Hume EB; Vijay AK; Sankaridurg P; Kumar N; Willcox MD
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):390-5. PubMed ID: 19710414
[TBL] [Abstract][Full Text] [Related]
11. Effect of propolis in the treatment of experimental Staphylococcus aureus keratitis in rabbits.
Oksuz H; Duran N; Tamer C; Cetin M; Silici S
Ophthalmic Res; 2005; 37(6):328-34. PubMed ID: 16138004
[TBL] [Abstract][Full Text] [Related]
12. Delayed-onset Pseudomonas keratitis after radial keratotomy.
Procope JA
J Cataract Refract Surg; 1997 Oct; 23(8):1271-2. PubMed ID: 9368176
[TBL] [Abstract][Full Text] [Related]
13. Comparative study on topical and oral administration of ofloxacin for Pseudomonas corneal ulcer in rabbits.
Shiao S; Isobe Y; Hatano H; Ohno S
Ophthalmologica; 1995; 209(3):155-9. PubMed ID: 7630623
[TBL] [Abstract][Full Text] [Related]
14. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
[TBL] [Abstract][Full Text] [Related]
15. Nona-D-arginine amide for prophylaxis and treatment of experimental Pseudomonas aeruginosa keratitis.
Karicherla P; Hobden JA
Curr Eye Res; 2010 Mar; 35(3):220-4. PubMed ID: 20373880
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor.
Barletta JP; Angella G; Balch KC; Dimova HG; Stern GA; Moser MT; van Setten GB; Schultz GS
Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):20-8. PubMed ID: 8550324
[TBL] [Abstract][Full Text] [Related]
17. Iontophoretic treatment of experimental pseudomonas keratitis in rabbit eyes using gentamicin-loaded hydrogels.
Frucht-Pery J; Raiskup F; Mechoulam H; Shapiro M; Eljarrat-Binstock E; Domb A
Cornea; 2006 Dec; 25(10):1182-6. PubMed ID: 17172895
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence.
Engel LS; Hill JM; Moreau JM; Green LC; Hobden JA; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):662-5. PubMed ID: 9501882
[TBL] [Abstract][Full Text] [Related]
19. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection.
Hazlett LD; McClellan SA; Barrett RP; Liu J; Zhang Y; Lighvani S
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):797-807. PubMed ID: 17251480
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium fortuitum keratitis. A comparison of topical ciprofloxacin and amikacin in an animal model.
Stevens RK; Holland GN; Paschal JF; Phinney RB; Berlin OG; Bruckner DA
Cornea; 1992 Nov; 11(6):500-4. PubMed ID: 1468211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]